Common Stock (Tables)
|
12 Months Ended |
Feb. 28, 2026 |
|---|
| Schedule of purchase warrants |
| Schedule of purchase warrants |
|
|
|
|
|
|
|
|
| |
|
Number of
Warrants |
|
|
Weighted Average
Exercise Price |
|
| Balance, February 28, 2025 |
|
|
5,288,316 |
|
|
$ |
1.56 |
|
| Exercised |
|
|
(1,149,743 |
) |
|
|
1.50 |
|
| Exercised |
|
|
(150,000 |
) |
|
|
1.88 |
|
| Issued |
|
|
3,000,000 |
|
|
|
1.65 |
|
| Issued |
|
|
1,000,000 |
|
|
|
2.15 |
|
| Expired |
|
|
(28,312 |
) |
|
|
8.22 |
|
| Issued |
|
|
300,000 |
|
|
|
1.65 |
|
| Adjustment to Exercise Price |
|
|
25,333 |
|
|
|
1.50 |
|
| Expired |
|
|
(10,000 |
) |
|
|
6.70 |
|
| Balance, February 28, 2026 |
|
|
8,275,594 |
|
|
$ |
1.64 |
|
|
| Schedule of share purchase warrants outstanding and exercisable |
| Schedule of share purchase warrants outstanding and exercisable |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
Number of Warrants |
|
|
|
Remaining Contractual |
|
|
|
| Exercise Price |
|
|
|
Outstanding |
|
|
|
Life (Years) |
|
|
Expiry Date |
| 1.50 |
|
|
|
3,975,594 |
|
|
|
3.82 |
|
|
December 23, 2029 |
| 1.65 |
|
|
|
3,000,000 |
|
|
|
1.14 |
|
|
April 20, 2027 |
| 2.15 |
|
|
|
1,000,000 |
|
|
|
1.14 |
|
|
April 20, 2027 |
| 1.65 |
|
|
|
300,000 |
|
|
|
1.16 |
|
|
April 27, 2027 |
| 1.64 |
|
|
|
8,275,594 |
|
|
|
|
|
|
|
|
| Schedule of stock option activity |
| Schedule of stock option activity | |
| | | |
| | |
| | |
Number of Stock Options | | |
Exercise Price | |
| Balance, February 28, 2025 | |
| 6,039,100 | | |
$ | 4.18 | |
| Cancelled/Forfeited | |
| — | | |
| — | |
| Balance, February 28, 2026 | |
| 6,039,100 | | |
$ | 4.18 | |
|
| Schedule of unvested restricted stock |
| Schedule of unvested restricted stock |
|
|
|
|
|
|
|
|
| |
|
Number of Unvested |
|
|
Weighted Average |
|
| |
|
Stock Options |
|
|
Grant Date Fair Value |
|
| Balance, February 28, 2025 |
|
|
2,303,300 |
|
|
$ |
5.16 |
|
| Vested – July 28, 2025 |
|
|
(529,700 |
) |
|
$ |
4.58 |
|
| Vested – December 28, 2025 |
|
|
(714,200 |
) |
|
$ |
6.46 |
|
| Balance, February 28, 2026 |
|
|
1,059,400 |
|
|
$ |
4.58 |
|
|
| Schedule of stock options |
| Schedule of stock options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Options Outstanding |
|
|
Options Exercisable |
|
|
|
|
|
Range of Exercise
Prices |
|
Outstanding at
February 28, 2026 |
|
|
Exercise Price |
|
|
Weighted Average Remaining
Contractual Term
(Years) |
|
|
Exercisable at February 28, 2026 |
|
|
Exercise Price |
|
|
Weighted Average Remaining
Contractual Term
(Years) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| $3.00 to $4.00 |
|
|
3,390,600 |
|
|
$ |
3.84 |
|
|
|
0.83 |
|
|
|
3,390,600 |
|
|
$ |
3.84 |
|
|
|
0.83 |
|
| $4.00 to $5.00 |
|
|
2,648,500 |
|
|
$ |
4.62 |
|
|
|
2.41 |
|
|
|
1,589,100 |
|
|
$ |
4.62 |
|
|
|
2.41 |
|
| |
|
|
6,039,100 |
|
|
|
|
|
|
|
|
|
|
|
4,979,700 |
|
|
|
|
|
|
|
|
|
|
| Individuals 40 [Member] |
|
| Schedule of valuation assumptions |
| Schedule of valuation assumptions | |
| | | |
| | |
| | |
February 28, 2026 | | |
February 28, 2025 | |
| Expected Risk-Free Interest Rate | |
| 1.06 | % | |
| 1.06 | % |
| Expected Volatility | |
| 15.27 | % | |
| 15.27 | % |
| Expected Life in Years | |
| 0.83 | | |
| 1.83 | |
| Expected Dividend Yield | |
| — | | |
| — | |
| Weighted-Average Grant Date Fair Value | |
$ | 6.46 | | |
$ | 6.46 | |
|
| Individuals 22 [Member] |
|
| Schedule of valuation assumptions |
| Schedule of valuation assumptions | |
| | | |
| | |
| | |
February 28, 2026 | | |
February 28, 2025 | |
| Expected Risk-Free Interest Rate | |
| 5.37 | % | |
| 5.37 | % |
| Expected Volatility | |
| 25.48 | % | |
| 25.48 | % |
| Expected Life in Years | |
| 2.41 | | |
| 3.41 | |
| Expected Dividend Yield | |
| — | | |
| — | |
| Weighted-Average Grant Date Fair Value | |
$ | 4.58 | | |
$ | 4.58 | |
|